MAPT and Alzheimer disease: This association between Aβ, NR4A2, synaptogyrin-3, and tau aggregates proposes an AD mechanism, with which Aβ aggregation leads to higher synaptogyrin-3 levels, which contribute to tau mediated synaptic dysfunction.